IV Ig Stalls Alzheimer Disease in 4 Patients
IV immunoglobulin (specifically Baxter’s Gammagard) may halt the progression of Alzheimer’s disease, according to a very small extension study of the...
Read More
-
About Pathophilia
Amyvid May Have Role in Predicting Further Cognitive Decline in MCI
A first-of-its-kind, longitudinal study of PET imaging for amyloid suggests that the brain scan may help predict further cognitive decline in patients with mild...
Read More
Alzheimer Biomarkers Indicate Very Early Disease Process
The process of Alzheimer disease begins years, if not decades, before the onset of clinical dementia, according to a newly published study in the New England Journal of...
Read More
Phase 3 Results of Anti-Amyloid MAbs in Alzheimer’s to Be Presented in October
The highly anticipated phase 3 results for two anti-amyloid MAbs in Alzheimer disease will be presented in October at the meeting of the “Clinical Trials on...
Read More
Phase 2 Results of Lilly’s Anti-Amyloid MAb: It Probably Works Like It’s Supposed To
Last Thursday, the phase 2 results of solanezumab, Lilly’s anti-amyloid MAb, were published online in Alzheimer’s & Dementia (the official journal of...
Read MoreElan Predicting FDA Approval of Bapineuzumab for AD? Telegraphing “Modicum of Benefit”
There’s tremendous speculation on the pending outcome of phase 3 results with bapineuzumab, 1 of 2 anti-amyloid compounds in late-stage development for Alzheimer...
Read More